Abstract Background The long-term outcomes of patients with in-stent restenosis (ISR) presenting with Acute Coronary Syndrome (ACS) are not well studied. This study aims at investigating the outcomes of patients with drug-eluting stents (DES)-ISR presenting with ACS undergoing percutaneous coronary intervention (PCI) with DCB or thin strut-DES. Methods Consecutive patients from the Dragon-Register with DES-ISR who underwent PCI with thin-DES or paclitaxel-DCB were enrolled [Figure 1]. Primary outcome was target lesion revascularization (TLR). Secondary outcomes were target vessel revascularization (TVR) and device-oriented composite endpoint [DOCE, cardiac death, TLR, and target vessel myocardial infarction (TV-MI)]. Propensity-score matching was used to adjust for baseline differences. Results A total of 1,317 patients were included in the pooled analysis of whom 585 (44.4%) were treated with a thin-DES and 732 (55,6%) with drug-coated balloons. In the crude analysis of patients with ACS (N = 697) undergoing PCI for ISR, thin-DES vs. DCB showed similar outcomes for TLR (HR = 1.21, 95% CI 0.78–1.86; P = 0.400), TVR (HR = 0.91, 95% CI 0.62–1.34; P = 0.641), MI (HR = 1.25, 95% CI 0.82–1.86; P = 0.281), TV-MI (HR = 0.91, 95% CI 0.43–1.90; P = 0.793), CV death (HR = 0.76, 95% CI 0.27–2.09; P = 0.589), and DOCE (HR = 1.04, 95% CI 0.70–1.54; P = 0.840). After propensity score matching (N = 606), the HRs remained non-significant for TLR (1.08, 95% CI 0.69–1.69; P = 0.731 [Figure 2]), TVR (0.88, 95% CI 0.59–1.31; P = 0.523), MI (1.24, 95% CI 0.80–1.91; P = 0.336), TV-MI (0.93, 95% CI 0.43–2.05; P = 0.865), CV death (0.75, 95% CI 0.26–2.18; P = 0.602), and DOCE (0.98, 95% CI 0.65–1.46; P = 0.904). Conclusions In patients with acute coronary syndrome undergoing percutaneous coronary intervention for in-stent restenosis, treatment with thin-DES was associated with a numerical reduction in the rates of TLR and DOCE compared with DCB. However, these differences did not achieve statistical significance in either the crude or propensity score–matched analyses.Figure 1For image description, please refer to the figure legend and surrounding text.Figure 2For image description, please refer to the figure legend and surrounding text.
The airways, gastrointestinal tract, and skin are continuously exposed to the external environment, yet each has developed distinct mechanisms for preserving its epithelial barrier. Many of these mechanisms rely on a shared set of ion channels whose functions change with cellular location and tissue architecture. This narrative review examines epithelial sodium channels (ENaC), the cystic fibrosis transmembrane conductance regulator (CFTR), calcium-activated chloride channels, and selected potassium and transient receptor potential (TRP) channels, together with the transport proteins that sustain their activity. In the airways, coordinated ion transport maintains surface hydration and supports mucociliary clearance. Along the gastrointestinal tract, region-specific transport pathways regulate gastric acid secretion, nutrient absorption, and intestinal fluid balance. In the skin, related proteins participate in sweat electrolyte reabsorption, epidermal homeostasis, and repair. Disruption of these pathways produces quite different clinical problems. CFTR mutations cause cystic fibrosis, whereas intestinal inflammation may secondarily suppress sodium absorption and alter potassium transport, aggravating diarrhea in inflammatory bowel disease. Experimental studies also implicate ion channels in keratinocyte migration and cutaneous sensory responses, although their clinical significance is less firmly established. Comparing these epithelial systems helps distinguish common molecular principles from organ-specific adaptations and highlights both established treatments and unresolved therapeutic questions.
INTRODUCTION:Psoriasis is a chronic inflammatory skin disease, in which psychological factors play an important role. In the studies of common markers of psoriasis and depression, the abnormal function of the stress axis in both diseases is highlighted, whereas interleukin-6 (IL-6) and interleukin-1 are indicated as particularly important. AIM:To evaluate the relationship between the affective temperament traits and the intensity of depressive symptoms in patients with psoriasis in the context of immunoenzymatic markers. MATERIAL AND METHODS:The study included 208 subjects. Severity of psoriasis was assessed by PASI. TEMPS-A was applied for the evaluation of affective temperament and BDI was used for the assessment of the intensity of depressive symptoms. The level of cytokines was determined by means of the immunoenzymatic method. RESULTS:Patients presented a specific profile of affective temperament, with higher scores on depressive, anxious and irritable dimensions. The severity of depressive symptoms correlated positively with the severity of psoriasis. A significant correlation was found between IL-6 and the severity of psoriasis in patients with depressive disorders and psoriasis. No similar correlation was found in patients without depressive disorder. CONCLUSIONS:Results of the present study show common mechanisms for psoriasis and depression. Specific traits of affective temperament may play an important role in the clinical picture of both diseases. Higher levels of IL-6 in patients with psoriasis predispose to more frequent occurrence of depressive disorders and the depressive dimension of affective temperament.